We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+2.5%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$12.2B
AUM Growth
+$835M
Cap. Flow
+$669M
Cap. Flow %
5.5%
Top 10 Hldgs %
49.1%
Holding
4,906
New
446
Increased
1,622
Reduced
1,207
Closed
366

Sector Composition

Rank Sector Weight
1 Energy 5.06%
2 Financials 4.8%
3 Technology 3.58%
4 Healthcare 2.6%
5 Communication Services 2.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IAU icon
1126
iShares Gold Trust
IAU
$63B
$229K ﹤0.01%
11,172
+64
+0.6% +$1.36K
TCP
1127
DELISTED
TC Pipelines LP
TCP
$229K ﹤0.01%
4,604
-154
-3% -$7.62K
JCP
1128
DELISTED
J.C. Penney Company, Inc.
JCP
$228K ﹤0.01%
34,215
+7,765
+29% +$64.8K
ALU
1129
DELISTED
Alcatel-Lucent
ALU
$228K ﹤0.01%
59,532
-1,120,420
-95% -$4.33M
CSL icon
1130
Carlisle Companies
CSL
$13.6B
$227K ﹤0.01%
2,557
+61
+2% +$5.4K
WLL
1131
DELISTED
Whiting Petroleum Corporation
WLL
$227K ﹤0.01%
80
+34
+74% +$161K
KSS icon
1132
Kohl's
KSS
$2.03B
$226K ﹤0.01%
4,744
+376
+9% +$17.4K
WAFD icon
1133
WaFd
WAFD
$2.72B
$226K ﹤0.01%
9,498
+7,910
+498% +$195K
CLDX icon
1134
Celldex Therapeutics
CLDX
$2.77B
$225K ﹤0.01%
955
+580
+155% +$126K
EQR icon
1135
Equity Residential
EQR
$25.4B
$225K ﹤0.01%
2,752
-692
-20% -$54.6K
PPH icon
1136
VanEck Pharmaceutical ETF
PPH
$945M
$225K ﹤0.01%
3,450
-3,654
-51% -$236K
BWP
1137
DELISTED
Boardwalk Pipeline Partners
BWP
$224K ﹤0.01%
17,276
-3,319
-16% -$41.1K
GERN icon
1138
Geron
GERN
$911M
$223K ﹤0.01%
46,000
-14,785
-24% -$59.4K
UVV icon
1139
Universal Corp
UVV
$1.34B
$223K ﹤0.01%
3,980
-900
-18% -$49.2K
IMGN
1140
DELISTED
Immunogen Inc
IMGN
$223K ﹤0.01%
16,447
-1,168
-7% -$14.4K
ARLP icon
1141
Alliance Resource Partners
ARLP
$3.18B
$222K ﹤0.01%
16,422
+2,118
+15% +$39.3K
PRLB icon
1142
Protolabs
PRLB
$1.86B
$222K ﹤0.01%
3,486
+225
+7% +$14.5K
SPTI icon
1143
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.4B
$222K ﹤0.01%
7,368
-1,968
-21% -$59.2K
TWO
1144
Two Harbors Investment
TWO
$1.27B
$222K ﹤0.01%
3,431
+1,638
+91% +$112K
ALGN icon
1145
Align Technology
ALGN
$12B
$221K ﹤0.01%
3,362
+1,798
+115% +$115K
IMMU
1146
DELISTED
Immunomedics Inc
IMMU
$221K ﹤0.01%
71,975
+35,000
+95% +$97.7K
CENT icon
1147
Central Garden & Pet Co
CENT
$2.74B
$220K ﹤0.01%
20,313
HBI
1148
DELISTED
Hanesbrands
HBI
$220K ﹤0.01%
7,477
-10,574
-59% -$317K
SON icon
1149
Sonoco
SON
$5.76B
$220K ﹤0.01%
5,372
-303
-5% -$12.6K
TTM
1150
DELISTED
Tata Motors Limited
TTM
$219K ﹤0.01%
7,436
+1,843
+33% +$53.5K

Similar funds

Creative Planning's Q4 2015 Portfolio in Review

As of Q4 2015, Creative Planning held 4,906 positions worth $12.2B, up 7.4% from $11.3B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Creative Planning deployed $669M of net new capital in Q4 2015, opening 446 new positions and adding to 1,622 existing holdings. Its largest new stake was Alphabet (Google) Class A: 378,080 shares worth $14.7M.

By sector, the portfolio is most concentrated in Energy at 5.1% of assets, down from 5.5% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Vanguard FTSE All-World ex-US ETF, an estimated $50.4M trimmed.

  • Creative Planning's largest Q4 2015 buy was Alphabet (Google) Class A: 378,080 shares worth $14.7M.
  • Creative Planning added most to Vanguard FTSE Developed Markets ETF in Q4 2015, an estimated $112M increase.
  • Creative Planning's biggest Q4 2015 reduction was Vanguard FTSE All-World ex-US ETF, cutting an estimated $50.4M.
  • Creative Planning fully exited DEALERTRACK TECHNOLOGIES, INC. COM STK in Q4 2015, selling an estimated $15.1M.
  • Creative Planning's ten largest holdings make up 49% of its $12.2B portfolio in Q4 2015.
  • Creative Planning opened 446 new positions and closed 366 in Q4 2015.
  • Creative Planning's portfolio value rose 7.4% quarter-over-quarter to $12.2B.

Based on Creative Planning's 13F filing for Q4 2015, filed 11 Jan 2016.